tiprankstipranks
CytoDyn (CYDY)
OTHER OTC:CYDY
US Market

CytoDyn (CYDY) Financial Statements

Compare
655 Followers

CytoDyn Financial Overview

CytoDyn's market cap is currently $305.65M. The company's EPS TTM is $-0.018; its P/E ratio is ―; CytoDyn is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 266.00K$ 0.00$ 0.00
Gross Profit$ -29.00K$ -175.00K$ 213.00K$ -1.80M$ -2.03M
Operating Income$ -18.06M$ -40.58M$ -71.91M$ -104.60M$ -74.65M
EBITDA$ -18.03M$ -40.40M$ -192.55M$ -92.75M$ 2.03M
Net Income$ -49.84M$ -79.82M$ -288.16M$ -174.02M$ -141.78M
Balance Sheet
Cash & Short-Term Investments$ 3.11M$ 2.54M$ 4.23M$ 33.94M$ 14.28M
Total Assets$ 11.14M$ 11.29M$ 29.18M$ 132.08M$ 50.51M
Total Debt$ 30.08M$ 35.41M$ 36.80M$ 63.47M$ 15.35M
Net Debt$ 26.97M$ 32.87M$ 32.57M$ 29.53M$ 1.07M
Total Liabilities$ 127.89M$ 120.79M$ 123.58M$ 153.10M$ 52.99M
Stockholders' Equity$ -116.76M$ -109.50M$ -94.40M$ -21.02M$ -2.48M
Cash Flow
Free Cash Flow$ -10.98M$ -25.11M$ -77.72M$ -117.69M$ -68.84M
Operating Cash Flow$ -10.98M$ -25.11M$ -77.72M$ -117.57M$ -68.80M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ -122.00K$ -41.09K
Financing Cash Flow$ 11.75M$ 29.93M$ 48.01M$ 137.35M$ 79.67M
Currency in USD

CytoDyn Earnings and Revenue History

CytoDyn Debt to Assets

CytoDyn Cash Flow

CytoDyn Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis